Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 3Phase 3 2Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

NIH 3NETWORK 2INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 90Prostatic Neoplasms 55Lymphoma 34Leukemia 32Carcinoma, Non-Small-Cell Lung 31Multiple Myeloma 30Head and Neck Neoplasms 30Colorectal Neoplasms 29Squamous Cell Carcinoma of Head and Neck 28Lung Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Colonic Neoplasms 24Leukemia, Myeloid, Acute 22Rectal Neoplasms 21Neoplasm Metastasis 20Sarcoma 19Ovarian Neoplasms 19Central Nervous System Neoplasms 18Uterine Cervical Neoplasms 17Hodgkin Disease 17Burkitt Lymphoma 15Brain Neoplasms 15Carcinoma, Ovarian Epithelial 14Pain 12Lymphoma, Follicular 12Urinary Bladder Neoplasms 11Lymphoma, Large B-Cell, Diffuse 11Fallopian Tube Neoplasms 11Endometrial Neoplasms 11Astrocytoma 11

Interventions

Vincristine 2Radiotherapy 2Ifosfamide 2Etoposide 2Doxorubicin 2Cyclophosphamide 2etoposide phosphate 1Topotecan 1Neoadjuvant Therapy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Dexrazoxane 1Chemotherapy, Adjuvant 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × NETWORK × Neuroectodermal Tumors, Primitive, Peripheral × Clear all
NCT00006734 2023-08-03

Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor

Children's Oncology Group

Phase 3 Completed
587 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00334867 2013-06-28

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

Children's Oncology Group

Phase 3 Withdrawn
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡